Melinda heads the New York City office of Bionest Partners, leading an outstanding team of consultants and analysts.
Melinda joined Bionest in 2011 and has led numerous client engagements, working with both large pharma companies and leading biotech firms in areas such as stakeholder engagement strategy, competitive positioning and differentiation, Go-to-Market strategy, portfolio/franchise strategy and implementation, and commercial landscape and assessment. Melinda’s areas of expertise include, among others, oncology, respiratory, CNS, diagnostics, and orphan diseases.
Melinda received a Ph.D. in Biomedical Engineering from Rutgers University, where her research was focused on the development of an in vitro microelectrode array tool to investigate cortical and spinal cord neuron functionality after injury. Melinda also holds a B.S. in Chemical Engineering from Northwestern University.